Nov 04, 2024 20:52
CVM - Cel-Sci Corporation
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
9.91 0.09 (0.94%) | --- | --- | --- | --- | 0.15 (1.53%) | 0.1 (1.01%) | 0.1 (1.01%) |
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- -1.36
- Basic P/E:
- Diluted P/E:
- -7.3529
- RSI(14) 1m:
- 0.0
- VWAP:
- 9.99
- RVol:
- 0.2674
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Dec 04, 2023 18:10
Jul 18, 2023 17:00
Jul 18, 2023 13:51
Jul 18, 2023 12:12
May 02, 2023 12:08
Mar 03, 2023 18:20
Dec 29, 2022 14:09
Oct 28, 2022 10:14
Aug 16, 2022 07:28